dexamethasone,teclistamab,daratumumab,lenalidomide
genmab,janssen
['daratumumab', ' lena', 'majestec,(-majestec-1),(-majestec1),(-majestec 1),(-majestec-3),(-majestec3),(-majestec 3),(-majestec-i),(-majestec i),(-majesteci)', 'lenalidomide', 'dexamethasone', 'teclistamab']
#ash22: amrita y. krishnan, m.d., will present details of the randomized, open-label, multicenter, phase 3 majestec-7 trial, which opened in q4 2022. 
City of Hope is a National Cancer Institute-designated comprehensive cancer center for cancer, diabetes and other life-threatening diseases.